Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
US11007217B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2017 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Aug 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions comprising silica particles having a mean size by standard particle sizing of between 0.5 nm and 20 nm are described for used in activating lymphocytes in culture or in whole blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.